{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T14:21:28Z","timestamp":1783952488742,"version":"3.55.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Hong Kong Jockey Club Charities Trust"},{"DOI":"10.13039\/100007625","name":"Cure Alzheimer\u2019s Fund","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007625","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hong Kong Research Grants Council","award":["16100424, 16101825, T12-611\/25-N, N_HKUST639\/25"],"award-info":[{"award-number":["16100424, 16101825, T12-611\/25-N, N_HKUST639\/25"]}]},{"DOI":"10.13039\/501100003452","name":"Innovation and Technology Commission","doi-asserted-by":"crossref","award":["ITCPD\/17-9"],"award-info":[{"award-number":["ITCPD\/17-9"]}],"id":[{"id":"10.13039\/501100003452","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Lingang Laboratory"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Zhang et al. reveal that astrocytic PAD2-mediated citrullination of vimentin drives a TLR4-dependent pro-inflammatory loop in microglia, linking glial crosstalk to impaired amyloid clearance and identifying a potential therapeutic and biomarker pathway in Alzheimer\u2019s disease.<\/jats:p>","DOI":"10.1186\/s13024-026-00974-w","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T14:00:25Z","timestamp":1783951225000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Breaking the glial loop: astrocytic PAD2 and citrullinated vimentin drive microglial dysfunction in Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"21","author":[{"given":"Jeff Y. L.","family":"Lam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"974_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2026.03.007","volume":"59","author":"J Zhang","year":"2026","unstructured":"Zhang J, Huang Y, Chen Y, et al. Astrocytic calcium-dependent enzyme PAD2 governs microglia activity to exacerbate amyloid pathology via citrullinated vimentin. Immunity. 2026;59:1.","journal-title":"Immunity"},{"key":"974_CR2","doi-asserted-by":"publisher","first-page":"1575453","DOI":"10.3389\/fnins.2025.1575453","volume":"19","author":"J Han","year":"2025","unstructured":"Han J, Zhang Z, Zhang P, et al. The roles of microglia and astrocytes in neuroinflammation of Alzheimer\u2019s disease. Front Neurosci. 2025;19:1575453.","journal-title":"Front Neurosci"},{"issue":"20","key":"974_CR3","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1016\/j.cell.2023.08.021","volume":"186","author":"M Jucker","year":"2023","unstructured":"Jucker M, Walker LC. Alzheimer\u2019s disease: From immunotherapy to immunoprevention. Cell. 2023;186(20):4260.","journal-title":"Cell"},{"key":"974_CR4","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.14336\/AD.2023.0727","volume":"15","author":"Q Deng","year":"2024","unstructured":"Deng Q, Wu C, Parker E, et al. Microglia and astrocytes in Alzheimer\u2019s disease: significance and summary of recent advances. Aging Dis. 2024;15:1537.","journal-title":"Aging Dis"},{"key":"974_CR5","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.tcb.2022.01.014","volume":"32","author":"K Yu","year":"2022","unstructured":"Yu K, Proost P. Insights into peptidylarginine deiminase expression and citrullination pathways. Trends Cell Biol. 2022;32:746.","journal-title":"Trends Cell Biol"},{"issue":"2","key":"974_CR6","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3233\/JAD-215302","volume":"85","author":"L Wang","year":"2022","unstructured":"Wang L, Chen H, Tang J, et al. Peptidylarginine deiminase and Alzheimer\u2019s disease. J Alzheimers Dis. 2022;85(2):473.","journal-title":"J Alzheimers Dis"},{"key":"974_CR7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12964-025-02062-w","volume":"23","author":"L Suprewicz","year":"2025","unstructured":"Suprewicz L, Fiedoruk K, Sk\u0142odowski K, et al. Extracellular vimentin is a damage-associated molecular pattern protein serving as an agonist of TLR4. Cell Commun Signal. 2025;23:64.","journal-title":"Cell Commun Signal"},{"key":"974_CR8","doi-asserted-by":"publisher","first-page":"602508","DOI":"10.3389\/fnins.2020.602508","volume":"14","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Chen Y, Xu C, et al. TLR4 targeting as a promising therapeutic strategy for Alzheimer disease treatment. Front Neurosci. 2020;14:602508.","journal-title":"Front Neurosci"},{"key":"974_CR9","doi-asserted-by":"publisher","first-page":"e361","DOI":"10.3346\/jkms.2020.35.e361","volume":"35","author":"J Lee","year":"2020","unstructured":"Lee J, Jang H, Kang SH, et al. Cerebrospinal fluid biomarkers for the diagnosis and classification of Alzheimer\u2019s disease spectrum. J Korean Med Sci. 2020;35:e361.","journal-title":"J Korean Med Sci"},{"issue":"7","key":"974_CR10","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.3390\/ijms26072857","volume":"26","author":"L Zhang","year":"2025","unstructured":"Zhang L, Wang J, Yan Y, et al. Vimentin fragmentation and its role in amyloid-beta plaque deposition in Alzheimer\u2019s disease. Int J Mol Sci. 2025;26(7):2857.","journal-title":"Int J Mol Sci"},{"key":"974_CR11","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41593-025-02125-8","volume":"29","author":"A Albertini","year":"2026","unstructured":"Albertini A, Zielonka M, Cuypers M-L, et al. The Alzheimer\u2019s therapeutic Lecanemab attenuates A\u03b2 pathology by inducing an amyloid-clearing program in microglia. Nat Neurosci. 2026;29:100.","journal-title":"Nat Neurosci"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-026-00974-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-026-00974-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-026-00974-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T14:00:27Z","timestamp":1783951227000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13024-026-00974-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":11,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["974"],"URL":"https:\/\/doi.org\/10.1186\/s13024-026-00974-w","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"28 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Yes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"GB is the Editor-in-Chief of Molecular Neurodegeneration and JYLL declares no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}